Skip to content

Clinical trials

Phase 1/2 Dementia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 1/2 Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20072
20081
20101
20123
20131
20141
20151
20193
20205
20213
20223
20231
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting7
Not yet recruiting4
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AC Immune SA2
Massachusetts General Hospital2
Arizona State University1
AviadoBio Ltd1
BioXcel Therapeutics Inc1
Brigham and Women's Hospital1
Chang Gung Memorial Hospital1
Chinese University of Hong Kong1
David Wilson1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia35
Alzheimer Disease20
Cognitive Dysfunction7
Central Nervous System Diseases4
Neurodegenerative Diseases4
Brain Diseases3
Dementia, Vascular2
Down Syndrome2
Frontotemporal Dementia2
Tauopathies2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.